We studied the effectiveness of levcromakalim, a potassium channel opener (KCO), in the prevention and reversal of spasm in arterial grafts used in coronary artery bypass operations, namely, internal mammary artery (IMA) and gastroepiploic artery (GEA). Methods Spasm was mimicked in vitro in arterial rings from 109 patients by increasing the vascular tension with noradrenaline, the thromboxane analogue U46619, endothelin-1 and K + .
Introduction
channels have been identified in vascular, cardiac and skeletal muscle cells, which are activated by drugs referred to as K + IMA and GEA are frequently used as arterial grafts for coronary revascularization [1] . Graft spasm during the channel openers (KCOs, e.g., cromakalim, pinacidil, nicorandil) and inhibited by sulphonylurea drugs such as perioperative or postoperative period limits the arterial graft longevity by reducing luminal blood flow [2, 3] . Endogenous glibenclamide [9] [10] [11] . Increased K + channel activity in spontaneous hypertensive rats and under hypoxic conditions spasmogenic agents such as noradrenaline, endothelin, thromboxane A 2 or depolarization of the cell membrane suggests that K + channel function might be changed in some cardiovascular diseases [12] [13] [14] . These channels have contribute to this effect [1, 4] . At present, nitrovasodilators, Ca ++ channel blockers and papaverine are used in the also been shown to be involved in the responses of various endogenous vasodilators including adenosine, prostacyclin, prevention and treatment of graft spasm. However, in some cases, these vasodilators remain ineffective [5] [6] [7] [8] . Thus, the nitric oxide and endothelium derived hyperpolarizing factor (EDHF) [11] . Thus, KCOs may possess beneficial therapeutic search for new, more effective agents to manage graft spasm is appropriate.
values in vasospastic disorders. The purpose of the present study was to examine the K + channels are involved in the regulation of electrophysiology of the cell membrane. Their activation results in responsiveness of IMA and GEA rings to levcromakalim, a K ATP channel opener, in order to determine the role of K , 15-100 mm) from patients who were not exposed to sulphonylurea type were constructed in both of the vessel segments. To oral antidiabetic agents. Some clinical characteristics of the determine whether pretreatment of IMA and GEA with patients and their drug therapies are given in Table 1 . Use levcromakalim would alter the responsiveness to the above of the vessels was approved by the Institutional Review spasmogens, the cumulative dose-response curves of these Boards of Baskent University and Oncology Hospital. All agents were repeated in the presence of levcromakalim in patients gave informed consent. Care was taken during both of the vessel rings with the exception of endothelin-1. harvesting of the vessels so as not to stretch and touch the Endothelin-1 induced contractions could not be reproduced endothelial surface. The vessel species were placed immediin the same preparation and thus the cumulative doseately into cold (4°C) Krebs Ringer-bicarbonate solution of response curve in the presence of levcromakalim was the following composition (mm): NaCl 118, KCl 4.7, performed in the adjacent ring of the same vessel. KH 2 PO 4 1.2, NaHCO 3 25, MgSO 4 .7H 2 O 1.2, CaCI 2 2.5, Levcromakalim was applied at concentrations corresponding glucose 11.1, and disodium EDTA 0.026.
to 50% of its maximum relaxant response (EC 50 ) in both of The vessels were cleaned of adherent connective tissues the arteries (see EC 50 values in Table 3 ) and added 30 min and cut into rings of 3-4 mm in length. Rings were before the second cumulative dose-response curve of suspended between two stainless steel L-shaped hooks in a contractile agent. 10 ml jacketed organ bath containing Krebs RingerTo determine the antispasmodic activity of levcromakalim, bicarbonate solution at 37°C and aerated with 95% O 2 and the concentration of each spasmogenic agent required to 5% CO 2 . One hook was fixed to a micrometric manipulator produce approximately the same contractile force (g ) in allowing adjustments in resting tension of the rings and the both IMA and GEA was determined and used to develop other was connected to a force displacement transducer submaximal contraction. This contractile force corresponds (Grass model FT 03 and May Com model FDT 10-A) for to 70-90% of the maximal contraction in IMA and 30-40% the measurement of isometric force. The optimal point of in GEA (low force). In an additional group of studies, GEA length-tension relation had been determined previously by rings were contracted to 70-90% of the maximal contraction repeated exposure to noradrenaline (5×10 −6 m) at different (high force) by increasing the concentrations of the levels of resting tension [15, 16] . In both of the arteries, 2 g contractile agents. To realize these experiments, the vessel was determined to be optimal for maximal noradrenaline rings were contracted with noradrenaline (5×10 −6 m for responsiveness.
IMA and 5×10 m) were assessed m) and preparations which developed a tension of less than on IMA and GEA rings precontracted with either of 1 g were discarded. The experiments were performed on the contractile agents. Relaxation capacities of the arteries endothelium intact rings of the vessels and the presence of were tested with sodium nitroprusside (SNP) which was endothelium was checked by functional relaxation to applied at maximal concentration (10
m) at the end of experiments. In time match control experiments, we genic agents were stable enough for the period required to construct the cumulative-relaxation curve of levcromakalim.
Parameters

IMA GEA
In some experiments, IMA and GEA rings were incubated for 30 min with indomethacin (10 All drugs used were purchased from Sigma Chemical Co. generous gifts of Upjohn Company (Kalamazoo, MI) and of the spasmogens that causes 50% of the maximal contraction (EC 50 ) are similar in IMA and GEA (Table 2) . SmithKline Beecham Pharmaceuticals (Welwyn, Herts), respectively. A stock solution of noradrenaline was prepared Both of the arterial grafts are more sensitive to endothelin-1 and U 46619 than the other two contractile agents. in 0.001n HCl and ascorbic acid was added to prevent oxidation. Levcromakalim and glibenclamide were dissolved in DMSO, and indomethacin in 5% (wt/vol) sodium
Effects of pretreatment with levcromakalim The pretreatment of IMA and GEA rings with levcromakalim, at concenbicarbonate. Other drugs were prepared in distilled water. DMSO was determined to have no effect on either of the trations corresponding to EC 50 values, significantly depressed the maximal contractions (relative or absolute) to noradrenacontractile agent induced responses.
line and U 46619 but not to endothelin-1 and K + ( Figure 2 and Table 2 ).
Statistical analysis
In regard to sensitivity, the EC 50 values for noradrenaline, U 46619 and K + were significantly (P<0.05) increased The results are given as mean±s.e.mean. The maximal contractile response (E max ) to each contractile agent was after pretreatment with levcromakalim indicating a shift of their dose-response curves to the right in both vessels. expressed according to K + (40 mm) induced contraction in that vessel ring. The maximal relaxations to levcromakalim However, no significant change was observed in the sensitivity to endothelin-1 (Table 2) . (E max ) were expressed as the percent decreases of the precontractions. The sensitivities of IMA and GEA to
In the absence of levcromakalim no change in contractile properties or in sensitivity was observed in either vessel. spasmogenic agents and levcromakalim are expressed as the effective concentration that elicited 50% of the maximal Furthermore, the addition of levcromakalim did not alter the resting tension of the arteries (data not shown). response (either contraction or relaxation, EC 50 ) and calculated separately for each dose-response curve by probit analysis. EC 50 values were expressed as negative log m. In Relaxation all experiments n is the number of patients from whom the vessels were obtained. Statistical analysis was determined by Levcromakalim induced dose-dependent relaxations in IMA and GEA (low and high force) rings ( Figure 3 and Table 3 ). Student's paired or unpaired t-test and a P value less than 0.05 was considered significant.
The maximal relaxations to levcromakalim (E max ) were markedly higher in GEA (either low or high force) than IMA with the exception of relaxation against endothelin-1 Results induced precontraction (Table 3) . Besides, high force GEA rings displayed partially reduced relaxations to levcromakalim Contraction compared with low force rings (Table 3) . On the other hand, SNP fully relaxed IMA and GEA rings precontracted The changes in contractile forces (g) induced by noradrenaline, the thromboxane analogue U 46619, endothelin-1 and with either of the spasmogens (Table 3) . In IMA donors, preoperative therapy with Ca ++ channel K + in IMA and GEA rings are shown in Figure 1 . The maximal absolute contractions (g) induced by each spasmogblockers did not influence the responsiveness of the artery to levcromakalim. For instance in the contraction of enic agent were considerably higher in GEA than IMA. However, the maximal relative contractions (E max , expressed noradrenaline, the maximal relaxation to levcromakalim was 63.09±3.45% (n=10) in IMA rings from donors that took as percent of contraction to K + , 40 mm) were identical in both of the arteries with the exception of noradrenaline Ca ++ channel blockers and was 63.31±6.02% (n=5) in rings from donors that did not take such therapy (P >0.05). (Table 2 ). On the other hand, the effective concentrations In regard to sensitivity, the effective concentrations of coronary artery bypass grafting [1, 4]. These above factors, either alone or in combination, may have implications in levcromakalim that causes 50% of the maximal relaxation (EC 50 ) against noradrenaline, U 46619 and K + contractions the genesis of graft spasm. Currently, graft spasm is controlled by nitrovasodilators, were significantly higher in IMA than in GEA rings (P<0.05). However, it was similar in both of the arteries nifedipine and papaverine used either systemically or topically [5] [6] [7] [8] . We and other researchers have previously shown that against endothelin-1 contraction (Table 3 ). These data indicate that levcromakalim produced higher antispasmodic these drugs are effective vasodilators against in vitro graft spasm [16, 21, 22] . However, in some cases, the above activity in GEA compared with IMA.
On the other hand, the time required for levcromakalim vasodilators may not provide the expected benefit in native graft spasm [6] [7] [8] . This may be related to the complexity of to cause maximal relaxation was similar in the two arteries (i.e. for endothelin-1 contraction; IMA: 8.5±0.76 min, n= spasm. Moreover, some unwanted side effects have been associated with these drugs. For instance, the negative 15 vs GEA: 9.56±0.81 min, n=8, P >0.05).
inotropic effect of nifedipine may aggravate congestive heart disease. The lack of tissue specificities of the available
Effects of indomethacin, l-NOARG and glibenclamide
The incubation of the arterial rings with the combination of vasodiators can cause coronary steal [23, 24] . In this respect, levcromakalim may offer some advantages over classical indomethacin (10 −5 m ), used to inhibit prostaglandin synthesis, and l-NOARG (10 −4 m), used to inhibit nitric vasodilators because of its relative selectivity for coronary blood flow and large dose range between its vasodilator and oxide synthesis, did not affect the relaxations to levcromakalim ( P>0.05, Table 4 ). However, the responses to levcromyocardial effects [24, 25] .
In the present study, we aimed to test the effectiveness makalim were completely abolished in both IMA and GEA rings in the presence of glibenclamide (10 −4 m), the K ATP of levcromakalim in the reversal and prevention of arterial graft spasm in vitro. For this purpose, we selected four channel blocker (Table 4) . Furthermore, addition of glibenclamide did not modify the resting tension of the arteries spasmogenic agents, namely, noradrenaline, endothelin-1, the thromboxane A 2 analogue U 46619 and K + to mimic (data not shown).
the native graft spasm. These agents produce contractions depending on Ca ++ influx through VOC and/or Ca ++ Discussion mobilization from intracellular stores by interfering with the synthesis of IP 3 and consequently lead to an increase in Graft spasm limits graft function by reducing luminal blood flow. Spasm can result from endothelial injury during intracellular free Ca ++ level. Conversely, levcromakalim, by causing hyperpolarization, prevents Ca ++ entry through surgical preparation which initiates the abnormal plateletendothelium interaction [17, 18] . Endothelial reactivity is VOC or inhibits agonist stimulated IP 3 synthesis and thus, reverses the contraction due to a decrease in intracellular accepted as a crucial factor in graft longevity [15, [18] [19] [20] . The mechanism of graft spasm is not clear. However, free Ca ++ concentration [9, 11]. We first investigated the efficacies and potencies of the above spasmogens in IMA elevated plasma levels of noradrenaline, thromboxane A 2 and endothelin-1 have been measured during or after and GEA in the absence and presence of levcromakalim. GEA, relaxations to levcromakalim were incomplete. This finding is consistent with the observation that increasing tone by using increasing concentrations of contractile agents GEA exhibited markedly higher responsiveness to these spasmogens than IMA when their contractile responses were decreased the responsiveness to vasodilators including KCOs [22, 26, 27] . The contraction of each vessel to equigram evaluated in terms of gram tension (absolute contraction). However, both arteries appeared so similar when contractile force was considered as a valid technique in the comparison of their relaxation capacities in vitro [20, 28] , although it is responses were compared in terms of K + induced contraction (relative contraction), except for noradrenaline. The accepted that such conditions may not be directly applicable in vivo. spasmogens displayed similar potency order in the arteries In both of the arteries, the relaxations to levcromakalim and SmithKline Beecham Pharmaceuticals for the gift of levcromakalim (BRL 38227). were completed approximately in 10 min. A previous study in IMA which compared the time to reach maximal relaxations of glyceryl trinitrate and nifedipine, reported that References glyceryl trinitrate took less time than nifedipine to achieve this [29] . Our results showed that levcromakalim is a rapidly
